Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
35,42 USD | +4,42 % | +9,35 % | +166,32 % |
Resumen de negocios
Número de empleados: 143
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jason Rhodes
FOU | Founder | 54 | 01/12/17 |
Rick Scalzo
DFI | Director of Finance/CFO | 38 | 01/12/19 |
John Najim
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/08/19 |
Chief Tech/Sci/R&D Officer | 63 | 27/01/20 | |
Chief Tech/Sci/R&D Officer | 61 | 28/06/19 | |
Wildon Farwell
CTO | Chief Tech/Sci/R&D Officer | 49 | 04/03/21 |
Ashish Dugar
CTO | Chief Tech/Sci/R&D Officer | - | 08/02/21 |
Susanna High
COO | Chief Operating Officer | 56 | 01/07/20 |
Amy Reilly
IRC | Investor Relations Contact | 51 | 01/07/20 |
Daniel Wilson
LAW | General Counsel | 53 | 01/06/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Edward Hurwitz
BRD | Director/Board Member | 60 | 01/11/18 |
David Lubner
BRD | Director/Board Member | 60 | 01/03/20 |
Dirk Kersten
BRD | Director/Board Member | 49 | 01/11/18 |
Jason Rhodes
FOU | Founder | 54 | 01/12/17 |
Carlo Incerti
BRD | Director/Board Member | 65 | 02/03/22 |
Chief Tech/Sci/R&D Officer | 61 | 28/06/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 99 164 649 | 98 702 810 ( 99,53 %) | 0 | 99,53 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+166,32 % | 3363,66 M | |
+21,85 % | 46,93 mil M | |
+37,63 % | 39,08 mil M | |
-8,05 % | 38,48 mil M | |
+29,04 % | 31,01 mil M | |
-13,75 % | 26,14 mil M | |
+10,65 % | 25,88 mil M | |
+38,43 % | 12,53 mil M | |
-6,92 % | 11,36 mil M | |
-12,29 % | 10,65 mil M |
- Bolsa de valores
- Acciones
- Acción DYN
- Empresa Dyne Therapeutics, Inc.